Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Chris Moore

Showing results (101-110 of 110) with videos related to

Pageof 11
Sort By:
You have reached the last page of results.This site can display upto 110 results.
Health Technology Assessment (Winchester, England)|November 2, 2024
Take-home naloxone in multicentre emergency settings: the TIME feasibility cluster RCTHelen Snooks, Jonathan Benger, Fiona Bell, et al.
Cell Reports|August 8, 2024
Kinetochore and ionomic adaptation to whole-genome duplication in Cochlearia shows evolutionary convergence in three autopolyploidsSian M Bray, Tuomas Hämälä, Min Zhou, et al.
Emergency Medicine Journal : EMJ|October 10, 2024
Transient Ischaemic attack Emergency Referral (TIER): randomised feasibility trial resultsAlan Watkins, Jenna Katherine Jones, Khalid Ali, et al.
Pilot and Feasibility Studies|March 23, 2018
Prehospital recognition and antibiotics for 999 patients with sepsis: protocol for a feasibility studyChris Moore, Jenna Bulger, Matt Morgan, et al.
Scientific Reports|September 21, 2021
Randomised feasibility study of prehospital recognition and antibiotics for emergency patients with sepsis (PhRASe)Jenna Jones, Susan Allen, Jan Davies, et al.
Scientific Reports|February 4, 2022
Author Correction: Randomised feasibility study of prehospital recognition and antibiotics for emergency patients with sepsis (PhRASe)Jenna Jones, Susan Allen, Jan Davies, et al.
Antiviral Research|November 15, 2017
HBsAg mRNA degradation induced by a dihydroquinolizinone compound depends on the HBV posttranscriptional regulatory elementTianlun Zhou, Timothy Block, Fei Liu, et al.
Hemasphere|November 15, 2024
Preclinical evaluation of the CD38-targeting engineered toxin body MT-0169 against multiple myelomaWassilis S C Bruins, Rosa Rentenaar, John Newcomb, et al.
Science Advances|November 1, 2024
Spatial multiplex analysis of lung cancer reveals that regulatory T cells attenuate KRAS-G12C inhibitor-induced immune responsesMegan Cole, Panayiotis Anastasiou, Claudia Lee, et al.
Nature Genetics|December 4, 2023
The role of APOBEC3B in lung tumor evolution and targeted cancer therapy resistanceDeborah R Caswell, Philippe Gui, Manasi K Mayekar, et al.
Pageof 11

Showing results (101-110 of 110) with videos related to

Sort By:
Pageof 11
You have reached the last page of results.This site can display upto 110 results.
Health Technology Assessment (Winchester, England)|November 2, 2024
Take-home naloxone in multicentre emergency settings: the TIME feasibility cluster RCTHelen Snooks, Jonathan Benger, Fiona Bell, et al.
Cell Reports|August 8, 2024
Kinetochore and ionomic adaptation to whole-genome duplication in Cochlearia shows evolutionary convergence in three autopolyploidsSian M Bray, Tuomas Hämälä, Min Zhou, et al.
Emergency Medicine Journal : EMJ|October 10, 2024
Transient Ischaemic attack Emergency Referral (TIER): randomised feasibility trial resultsAlan Watkins, Jenna Katherine Jones, Khalid Ali, et al.
Pilot and Feasibility Studies|March 23, 2018
Prehospital recognition and antibiotics for 999 patients with sepsis: protocol for a feasibility studyChris Moore, Jenna Bulger, Matt Morgan, et al.
Scientific Reports|September 21, 2021
Randomised feasibility study of prehospital recognition and antibiotics for emergency patients with sepsis (PhRASe)Jenna Jones, Susan Allen, Jan Davies, et al.
Scientific Reports|February 4, 2022
Author Correction: Randomised feasibility study of prehospital recognition and antibiotics for emergency patients with sepsis (PhRASe)Jenna Jones, Susan Allen, Jan Davies, et al.
Antiviral Research|November 15, 2017
HBsAg mRNA degradation induced by a dihydroquinolizinone compound depends on the HBV posttranscriptional regulatory elementTianlun Zhou, Timothy Block, Fei Liu, et al.
Hemasphere|November 15, 2024
Preclinical evaluation of the CD38-targeting engineered toxin body MT-0169 against multiple myelomaWassilis S C Bruins, Rosa Rentenaar, John Newcomb, et al.
Science Advances|November 1, 2024
Spatial multiplex analysis of lung cancer reveals that regulatory T cells attenuate KRAS-G12C inhibitor-induced immune responsesMegan Cole, Panayiotis Anastasiou, Claudia Lee, et al.
Nature Genetics|December 4, 2023
The role of APOBEC3B in lung tumor evolution and targeted cancer therapy resistanceDeborah R Caswell, Philippe Gui, Manasi K Mayekar, et al.
Pageof 11